BiognostiX technology will enable the translation of your current diagnostic tests to a novel microfluidics based platform.

This will lead to new tests that are easy to perform, cost effective and potentially point-of-use.

BiognostiX is an  EU funded research project under Framework Programme 7 to develop a novel, fibre-based micro-fluidic system with multiplex capability. The members of the consortium includes FFEi Ltd, Cambridge University, VTT Technical Research Center of Finland, Parco Technologico Padano, Proteomika and Prionics.